ITGR · Integer Holdings Corp · Executive Compensation

$126.70 -0.05 (-0.04%) At close · Oct 20

S&P 600 member Russell 2000 member Rebalance outlook locked

Market Cap

$4.31B

33.99M

Volume · Oct 20 904.75K Avg daily vol (3M) 1.06M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Dziedzic	Former President and CEO	$1,235,000	—	$5,999,951	—	$1,323,766	$112,615	$8,671,332
Payman Khales	President and CEO	$637,019	—	$2,149,878	—	$363,631	$61,332	$3,211,860
Diron Smith	Executive Vice President and Chief Financial Officer	$499,135	—	$1,724,858	—	$321,007	$23,964	$2,568,964
Andrew Senn	President, Cardio & Vascular	$434,135	$250,000	$799,959	—	$195,190	$28,640	$1,707,924
Jim Stephens	President, Cardiac Rhythm Management & Neuromodulation	$504,423	—	$949,874	—	$227,853	$10,500	$1,692,650
Lindsay K. Blackwood	Senior Vice President, General Counsel and Corporate Secretary	$365,385	$50,000	$1,024,856	—	$203,656	—	$1,643,897

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Dziedzic	President and Chief Executive Officer	$1,235,000	—	$5,499,932	—	$1,811,560	$128,887	$8,675,379
Diron Smith	Executive Vice President and Chief Financial Officer	$440,000	—	$1,599,937	—	$410,718	$22,142	$2,472,797
Payman Khales	President, Cardio & Vascular	$550,000	—	$899,905	—	$474,819	$52,086	$1,976,810
John Harris	Executive Vice President, Global Operations and Manufacturing Strategy	$419,395	—	$1,044,797	—	$313,792	$89,498	$1,867,482
Jim Stephens	President, Cardiac Rhythm Management & Neuromodulation	$461,827	—	$709,900	—	$411,607	$17,270	$1,600,604

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Dziedzic	President and Chief Executive Officer	$1,227,596	—	$5,499,971	—	$1,913,184	$97,746	$8,738,497
Payman Khales	President, Cardio & Vascular	$528,846	—	$2,899,951	—	$572,027	$35,822	$4,036,646
Jason Garland	Former Executive Vice President and Chief Financial Officer	$195,408	—	$1,524,969	—	—	$606,155	$2,326,532
Jennifer M. Bolt	Former Executive Vice President, Global Operations and ESG	$399,392	—	$574,963	—	—	$526,568	$1,500,923
Kirk Thor	Executive Vice President and Chief Human Resources Officer	$396,827	—	$544,971	—	$365,446	$29,371	$1,336,615
McAlister Marshall	Senior Vice President, General Counsel, Chief Ethics and Compliance Officer and Corporate Secretary	$430,481	—	$479,940	—	$396,438	$27,971	$1,334,830
Diron Smith	Executive Vice President and Chief Financial Officer	$345,865	—	$629,987	—	$289,181	$16,174	$1,281,207

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Dziedzic	President and Chief Executive Officer	$1,157,692	—	$9,499,913	—	$742,810	$94,822	$11,495,237
Jason Garland	Former Executive Vice President and Chief Financial Officer	$541,327	—	$2,364,986	—	$221,029	$33,207	$3,160,549
Payman Khales	President, Cardio & Vascular	$443,865	—	$1,649,924	—	$176,139	$32,919	$2,302,847
Carter Houghton	President, Electrochem and Power Solutions	$381,192	$385,000	$499,980	—	$131,328	$21,069	$1,418,569
Jennifer M. Bolt	Former Executive Vice President, Global Operations and ESG	$441,539	—	$559,924	—	$125,865	$31,224	$1,158,552

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Dziedzic	President and Chief Executive Officer	$994,712	—	$4,999,987	—	$854,994	$72,382	$6,922,075
Jason Garland	Former Executive Vice President and Chief Financial Officer	$504,981	—	$1,089,930	—	$256,485	$30,819	$1,882,215
Payman Khales	President, Cardio & Vascular	$418,673	—	$739,986	—	$193,190	$33,298	$1,385,147
Jennifer M. Bolt	Former Executive Vice President, Global Operations and ESG	$407,885	—	$714,916	—	$180,391	$27,563	$1,330,755
Joel Becker	President, Cardiac Rhythm Management & Neuromodulation	$418,673	—	$589,963	—	$186,768	$31,768	$1,227,172

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Dziedzic	President and Chief Executive Officer	$1,000,250	—	$3,999,827	—	$880,220	$43,487	$5,923,784
Jason Garland	Executive Vice President and Chief Financial Officer	$498,846	—	$925,889	—	$259,400	$18,512	$1,702,647
Payman Khales	President, Cardio & Vascular	$410,769	—	$493,870	—	$204,563	$26,057	$1,135,259
Joel Becker	President, Cardiac Rhythm Management & Neuromodulation	$423,269	—	$493,870	—	$155,475	$11,707	$1,084,321
Jennifer M. Bolt	Executive Vice President, Global Operations and ESG	$402,885	—	$399,927	—	$186,036	$26,911	$1,015,759

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Dziedzic	President and Chief Executive Officer	$913,375	—	$3,518,822	—	$1,241,824	$70,868	$5,744,889
Jason Garland	Executive Vice President and Chief Financial Officer	$445,000	—	$799,869	—	$357,513	$277,552	$1,879,934
Carter Houghton	President, Electrochem and Power Solutions	$215,385	—	$889,861	—	$120,831	$132,370	$1,358,447
Payman Khales	President, Cardio & Vascular	$340,625	—	$449,968	—	$273,658	$27,312	$1,091,563
Jennifer M. Bolt	Senior Vice President, Global Operations and ESG	$337,500	$50,050	$374,729	—	$274,590	$28,586	$1,065,455

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Dziedzic	President and Chief Executive Officer	$869,125	—	$3,314,875	—	$1,109,873	$89,752	$5,383,625
Jason Garland	Executive Vice President and Chief Financial Officer	$99,231	$50,000	$551,809	—	$64,500	$30,744	$796,284

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Dziedzic	President & Chief Executive Officer	$571,115	$166,154	$3,086,165	$1,008,113	—	$57,225	$4,888,772

Executive changes

Person	Role	Change	Effective	Filed
Jim Stephens	Executive Vice President, Special Projects	Appointed	2026-06-29	2026-06-26
Aaron Kapito	new independent director	Appointed	—	2026-03-12
James Flanagan	independent director	Appointed	—	2026-03-12
Aaron Kapito	Investor Designated Director	Appointed	2026-03-12	2026-03-12
James F. Flanagan	New Company Director	Appointed	2026-03-12	2026-03-12
Joseph W. Dziedzic	CEO	Retired	2025-10-24	2025-10-24
Payman Khales	President and Chief Executive Officer	Appointed	2025-10-24	2025-10-24
Payman Khales	member of the Board	Appointed	2025-10-24	2025-10-24
Michael J. Coyle	Board of Directors	Appointed	2025-07-10	2025-07-10
Joseph W. Dziedzic	director on the Board	Resigned	2025-10-24	2025-04-24
Payman Khales	President and CEO	Appointed	2025-10-24	2025-04-24
Joseph W. Dziedzic	President and Chief Executive Officer	Retired	2025-10-24	2025-04-24
McAlister C. Marshall, II	Senior Vice President, General Counsel and Corporate Secretary	Retired	2025-01-31	2024-07-08
Diron Smith	Executive Vice President and Chief Financial Officer	Appointed	2023-10-09	2023-10-10
Diron Smith	Interim Chief Financial Officer	Appointed	2023-05-08	2023-05-08
Joel Becker	President, Cardiac Rhythm Management & Neuromodulation	Resigned	2022-10-07	2022-10-11

Leadership

Payman Khales CEO, Board Member
Lindsay K. Blackwood General Counsel
McAlister Marshall General Counsel
Aaron Kapito Board Member
Alvin (Tyrone) Jeffers Board Member
Cheryl C. Capps Board Member
Donald J. Spence Board Member
Filippo Passerini Board Member
James F. Flanagan Board Member
James F. Hinrichs Board Member
James Flanagan Board Member
M. Craig Maxwell Board Member
Michael J. Coyle Board Member
Pamela G. Bailey Board Member
Sheila Antrum Board Member

Key facts CIK 1114483 CUSIP 45826H109 13F (30d) 45 filings 39 filers Visit website Investor relations